The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCE INC | COM | 00032Q104 | 1,710,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
AEROVATE THERAPEUTICS INC | COM | 008064107 | 3,450,529 | 201,197 | SH | SOLE | 201,197 | 0 | 0 | |||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 16,808,400 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | |||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 3,571,601 | 347,432 | SH | SOLE | 347,432 | 0 | 0 | |||
AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 3,921,184 | 238,225 | SH | SOLE | 238,225 | 0 | 0 | |||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 2,512,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 11,863,500 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | |||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 16,398,000 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | |||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 1,523,250 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 8,925,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 2,500,441 | 300,173 | SH | SOLE | 300,173 | 0 | 0 | |||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 720,850 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | |||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 7,904,600 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | |||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 4,011,750 | 22,500 | SH | SOLE | 22,500 | 0 | 0 | |||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 1,408,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
BIOMEA FUSION INC | COM | 09077A106 | 4,170,500 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | |||
BIOXCEL THERAPEUTICS INC | COM | 09075P105 | 865,800 | 130,000 | SH | Call | SOLE | 130,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 722,400 | 42,000 | SH | SOLE | 42,000 | 0 | 0 | |||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 6,808,000 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | |||
FIBROGEN INC | COM | 31572Q808 | 98,550 | 36,500 | SH | SOLE | 36,500 | 0 | 0 | |||
FUSION PHARMACEUTICALS INC | COM | 36118A100 | 1,927,304 | 412,699 | SH | SOLE | 412,699 | 0 | 0 | |||
IMMUNOGEN INC | COM | 45253H101 | 1,887,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
INCYTE CORP | COM | 45337C102 | 4,046,250 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | |||
INHIBRX INC | COM | 45720L107 | 908,600 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | |||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 704,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 2,710,625 | 12,500 | SH | SOLE | 12,500 | 0 | 0 | |||
KRYSTAL BIOTECH INC | COM | 501147102 | 2,348,000 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 12,705,000 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | |||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 201,513 | 61,250 | SH | SOLE | 61,250 | 0 | 0 | |||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 7,226,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 16,830,000 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | |||
MORPHIC HLDG INC | COM | 61775R105 | 1,146,600 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 2,208,860 | 154,250 | SH | SOLE | 154,250 | 0 | 0 | |||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 1,758,941 | 280,981 | SH | SOLE | 280,981 | 0 | 0 | |||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 6,214,500 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | |||
PTC THERAPEUTICS INC | COM | 69366J200 | 678,172 | 16,675 | SH | SOLE | 16,675 | 0 | 0 | |||
RAIN ONCOLOGY INC | COM | 75082Q105 | 390,000 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | |||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 8,666,600 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | |||
REPLIMUNE GROUP INC | COM | 76029N106 | 252,285 | 10,865 | SH | SOLE | 10,865 | 0 | 0 | |||
REVANCE THERAPEUTICS INC | COM | 761330109 | 13,287,750 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | |||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 1,490,250 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
ROIVANT SCIENCES LTD | SHS | G76279101 | 645,120 | 64,000 | SH | SOLE | 64,000 | 0 | 0 | |||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 9,734,200 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | |||
SPDR SER TR | S&P BIOTECH | 78464A870 | 24,960,000 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 723,095 | 27,578 | SH | SOLE | 27,578 | 0 | 0 | |||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 7,325,500 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 2,710,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
TG THERAPEUTICS INC | COM | 88322Q108 | 20,493,000 | 825,000 | SH | SOLE | 825,000 | 0 | 0 | |||
UNIQURE NV | SHS | N90064101 | 2,463,900 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | |||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 204,290 | 31,000 | SH | SOLE | 31,000 | 0 | 0 | |||
VAXCYTE INC | COM | 92243G108 | 13,983,200 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | |||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 2,325,400 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | |||
VIKING THERAPEUTICS INC | COM | 92686J106 | 10,536,500 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | |||
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 3,679,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 5,709,600 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | |||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 7,122,500 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | |||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 2,821,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 |